Mar Esteban-Ortega

ORCID: 0000-0001-5585-4589
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Diseases and Behçet’s Syndrome
  • Retinal and Optic Conditions
  • Retinal Diseases and Treatments
  • Systemic Lupus Erythematosus Research
  • Glaucoma and retinal disorders
  • Vasculitis and related conditions
  • Intensive Care Unit Cognitive Disorders
  • Cytomegalovirus and herpesvirus research
  • Geriatric Care and Nursing Homes
  • Frailty in Older Adults
  • Ocular Surface and Contact Lens
  • Renal Diseases and Glomerulopathies
  • Syphilis Diagnosis and Treatment
  • SARS-CoV-2 and COVID-19 Research

Hospital Universitario Infanta Sofía
2019-2024

Universidad Europea
2019-2024

Inflammatory adverse events following COVID-19 vaccination are being reported amidst the growing concerns regarding vaccine's immunogenicity and safety, especially in patients with pre-existing inflammatory conditions.Multinational case series of diagnosed an ocular event within 14 days collected from 40 centres over a 3 month period 2021.Seventy presented vaccination. The mean age was 51 years (range, 19-84 years). most common were anterior uveitis (n = 41, 58.6%), followed by posterior 9,...

10.1186/s12348-021-00275-x article EN cc-by Journal of Ophthalmic Inflammation and Infection 2022-01-04

ObjectivesTo describe the clinical characteristics, 30-day mortality, and associated factors of patients living in nursing homes (NH) with COVID-19, from March 20 to June 1, 2020.DesignThis is a retrospective study. A geriatric hospital-based team acted as consultant coordinated care older people NHs hospital.Setting ParticipantsA total 630 aged 70 Coronavirus Disease 2019 COVID-19 55 NHs.MethodsA logistic regression was performed analyze mortality. In addition, Kaplan-Meier curves were...

10.1016/j.jamda.2020.12.003 article EN other-oa Journal of the American Medical Directors Association 2020-12-12

Background: The aim of this study was to describe the characteristics patients with uveitis associated an immunologic or idiopathic disease that requires immunosuppressive treatment and response such treatments in real clinical practice. Methods: An observational, descriptive, longitudinal, retrospective a cohort diagnosed noninfectious performed. To assess treatment, we evaluated change visual acuity, vitritis, presence macular edema. Results: We included 356 patients. Overall, 12% required...

10.3390/jcm13051402 article EN Journal of Clinical Medicine 2024-02-28

To describe the characteristics of patients with uveitis associated an immunologic or idio-pathic disease that requires immunosuppressive treatment and response to such treatments in real clinical practice. Observational, descriptive, longitudinal, retrospective study a cohort diagnosed idiopathic autoimmune disease-related uveitis. assess we have evaluated change visual acuity vitritis presence macular edema. We included 356 patients. Twelve percent required systemic corticosteroids 66...

10.20944/preprints202401.0182.v1 preprint EN 2024-01-03

Uveitis is the inflammation of middle layer eye, uvea, and a major cause blindness. None instruments used in clinical practice are, themselves, sufficient to evaluate course uveitis. Therefore, it necessary develop enabling standardized measurement inflammatory activity. We developed composite disease activity index for patients with uveitis known as UVEDAI, which considers overall eye. The objective this study was validate ocular inflammation, UVEDAI. A multicenter cross-sectional involving...

10.1007/s40123-023-00654-8 article EN cc-by-nc Ophthalmology and Therapy 2023-01-23

Purpose: To estimate the incidence rate (IR) and identify risk factors associated to inflammatory relapse after immunosuppressive drug (ISD) discontinuation in noninfectious uveitis patients.Methods: Multicenter longitudinal retrospective study, including patients from four clinics followed-up until December 2018. Hazard ratios for different variables were estimated using multivariable Cox models.Results: 32 (34 episodes of ISD discontinuation) analyzed (median maximum follow-up time: 2.4...

10.1080/09273948.2019.1681469 article EN Ocular Immunology and Inflammation 2019-11-11

This was a multicenter, prospective, longitudinal, observational study involving eight Spanish tertiary hospitals to determine the interobserver reliability of an uveitis disease activity index, (UVEDAI) and assess its sensitivity change in patients with receiving pharmacologic treatment. Patients aged ≥ 18 years diagnosed active noninfectious were included. A complete baseline assessment performed by two ophthalmologists who determined ocular inflammatory using UVEDAI index independently...

10.1007/s40123-024-00943-w article EN cc-by-nc Ophthalmology and Therapy 2024-04-18
Coming Soon ...